Insights, opportunities and challenges

An analysis of the European e-pharmacy market

SBI international epharmacy studies 1920 1080 2

Reading time: 7 minutes

In Europe, we are witnessing a remarkable transformation in the digital pharmaceutical sector. Technological breakthroughs and new mail order regulations have revolutionised the online pharmacy market which results in exciting opportunities and new challenges. The global e-pharmacy market could have a size which is twice as big in the next few years, with an expected growth of 65% in Europe by 2028. Pharmaceutical companies face crucial strategic considerations in order to succeed in this dynamic environment.

An overview of Europe's digital pharmaceutical markets

The European e-pharmacy market is diverse and dynamic, having a total market size of 7.5 billion euros in the eight most important countries. Germany leads with 3,570 million euros, followed by the UK and France. Each country includes its own special features and regulations to this growing sector. Austria, for example, is characterised by the rapid introduction of digital healthcare solutions, while France is known for its demanding consumers and advanced digital infrastructure. These specific characteristics of the countries offer opportunities, but also challenges for players in the e-pharmacy sector, as each market must be considered individually and special features should be known.

Europe's most successful e-pharmacies

The analysis of the most successful e-pharmacies in Europe offers fascinating insights. In Austria, Shop Apotheke AT is the most dominant online pharmacy, while Dr Max leads this market in the Czech Republic. France's Atida (Santediscount) and Italy's Farmaè are also leaders in their markets. These pharmacies are characterised by high sales, a strong social media presence and a high number of customers. According to the user data, women make up the majority of e-pharmacy users in most European countries, with women aged 25-54 being the most active.

  • Austria: Shop Apotheke AT leads the ranking and dominates the market with an annual volume of over 100 million euros and more than 30 million visitors. As a part of the Redcare Pharmacy Group, it is characterised by a high visibility and social media presence which is especially the case with Facebook where 70,000 people follower Shop Apotheke AT.
  • Czech Republic: Dr Max leads e-pharmacy-market in this country with an annual volume of more than 140 million euros and 66 million visitors. The pharmacy is known for its big social media community and offers a 10% discount on average, however the producs on Dr Max are more expensive than in other top pharmacies.
  • France: Atida (Santediscount) is the leader with more than 160 million euros of annual sales and 18 million visitors. The pharmacy belongs to the the Atida Group and is characterised by a strong social media presence, particularly on Facebook and Instagram, and offers an avarage amount of 20% discount for its products.
  • Italy: Farmaè holds the top position, although, with 20% discount on average, it doesn't belong to the cheapest e-pharmacies in the country. With 23 million visitors per year and a big Facebook community with 114 followers, it even surpasses Redcare, the well known online pharmacy.
  • Poland: With more than 200 million euros in sales and 122 million visitors, Doz.pl is the undisputed market leader in Poland. Despite its leading position in sales and visibility, competitors such as Wapteka and Aptekaolmed have a stronger social media presence.
  • Spain: PromoFarma is leading with a volume of almost 80 million euros and 18 million visitors. As a part of the DocMorris Group, the pharmacy stands out with a high visibility index in the SEO-sector and a strong presence on Facebook and Instagram.
  • UK: With over 50 million visitors, Lloyds Pharmacy is ahead of Boots and Superdrug when it comes to traffic and sales in the e-pharmacy sector. In regard to social media as well as the visibility index, however, it does not quite reach the figures of its competitors who are more successful in these areas.

The three biggest challenges in pharmaceutical ecommerce

The digital pharma market is full of opportunities, but also challenges. With this emerging sector in mind, pharmaceutical companies have to face important strategic considerations. In order to make informed decisions, it is essential for them to understand the market of the individual countries as well as the shops they interact with. This circumstance results in a big amount of data that needs to be collected, processed and understood. A process that causes a multitude of challenges. The biggest challenges for pharmaceutical manufacturers are:

1. Loss of time due to manual processes: Time-consuming manual monitoring of product KPIs in all shops

2. Difficult resource allocation: High costs for human resources and little focus on strategic issues

3. High effort for manual data management: Difficult to analyse and interpret large amounts of data

Smile AI offers solutions to these challenges with the help of analyses and reports, which are automated by the Smile Analyze software, which enable efficient monitoring, evaluation and improvement of all KPIs that are important for a successful pharmaceutical ecommerce business.

SBI Blog E-pharmacy market EN

Automated solutions and AI as the key to success

Automated solutions and artificial intelligence are crucial for the success in pharma e-commerce. Smile Analyze and our Content Copilots are advanced tools that support pharmaceutical companies when it comes to the accurate monitoring of their market performance, the analysis of competitors and the improvement of their online presence. These tools provide quick solutions to complex questions and enable companies to focus on innovative projects and strategic decisions.

The International E-pharmacies 2024 study series from Smile AI

Having a look at some European countries shows that the situation of e-pharmacies currently differs in the individual states. There are major differences in terms of sales potential, regulatory requirements and the development status of e-pharmacies. In the "International E-pharmacy Studies 2024" series of studies, we analyse the UK, France, Italy, Spain, the Czech Republic, Poland and Austria regarding their market situation and the performance of their best e-pharmacies. We examine them in terms of key performance indicators such as sales, traffic, pricing, SEO, social media and user demographics. For each country, the studies provide an in-depth analysis and practical recommendations for the daily challenges that pharmaceutical companies face in regard to the ecommerce. Get an overview with the help of our comprehensive studies.

View the international studies for all countries now 

View the study of the UK market now

Summary

  • Growth of the e-pharmacy market: The European e-pharmacy market is experiencing a significant growth, with an expected increase of 65% by 2028. Germany, the UK and France are the leaders in this sector.
  • Country-specific market characteristics: Each country shows unique characteristics and differences in their market volume. While the online sales of prescribed drugs or the e-prescription are already a standard in some countries, other countries are still waiting for these characteristics.
  • Challenges in pharmaceutical e-commerce: Loss of time due to manual processes, difficult resource allocation and high expenditure for manual data management are the main problems.
  • Solutions with the help of Smile AI: Smile AI offers automated analyses and reports that enable time savings and efficient use of resources in order to overcome these challenges.
  • Importance of automation and AI: Automated solutions and artificial intelligence, especially with the help of tools, such as Smile Analyze and the Content Copilots, are crucial for the success in the digital pharmaceutical market.
  • Leading online pharmacies in Europe: Successful e-pharmacies, such as Shop Apotheke AT in Austria and Dr Max in the Czech Republic, show high sales and a strong presence on social media.
  • User behaviour: In most European countries, women make up the majority of e-pharmacy users, with a dominant age group of 25 to 54 years.
  • International e-pharmacies 2024 study series: The study series provides comprehensive insights into sales, SEO, social media, pricing, traffic and user data from 7 different countries in order to support pharmaceutical companies with the optimisation of their ecommerce strategies.

Smile AI GmbH
Sonnenstraße 14
D-80331 München
Telefon +49 89 242156500

info@smileai.de